{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T10:41:56Z","timestamp":1773139316771,"version":"3.50.1"},"reference-count":48,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202935\/Z\/16\/Z"],"award-info":[{"award-number":["202935\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2023,1,29]]},"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Substandard and falsified (SF) antiretrovirals (ARVs) risk poor outcomes and drug resistance, potentially affecting millions of people in need of treatment and prevention. We assessed the available evidence on SF ARV and related medical devices to discuss their potential public health impact.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Searches were conducted in Embase, PubMed, Google, Google Scholar, Web of Science and websites with interest in ARV quality in English and French up to 30 November 2021. Publications reporting on the prevalence of SF ARV were assessed in a quantitative analysis using the Medicine Quality Assessment Reporting Guidelines (MEDQUARG).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 205 publications on SF ARV and 11 on SF medical devices. Nineteen prevalence surveys of SF ARV, published between 2003 and 2021, were included, with no surveys relevant to SF medical devices. The prevalence survey sample size ranged from 3 to 2630 samples (median (Q1\u2013Q3): 16.0 (10.5\u201344.5); 3 (15.8%) used random outlet sampling methods. Of the 3713 samples included in the prevalence surveys, 1.4% (n=51) failed at least one test. Efavirenz, nevirapine and lamivudine-nevirapine-stavudine combination were the most surveyed ARV with failure frequencies of 3.6% (7\/193), 2.6% (5\/192) and 2.8% (5\/177), respectively. The median (Q1%\u2013Q3%) concordance with the MEDQUARG criteria was 42.3% (34.6%\u201355.8%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These results suggest that there are few data in the public domain of the quality of ARV in supply chains; the proportion of SF ARV is relatively low in comparison to other classes of essential medicines. Even a low proportion of the ARV supply chain being poor quality could make a large difference in the HIV\/AIDS international landscape. The 95-95-95 target for 2026 and other international targets could be greatly hampered if even 1% of the millions of people taking ARV (for both prevention and prophylaxis) receive medicines that do not meet quality standards. More surveillance of SF ARV is needed to ensure issues are detected.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2022-011423","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T10:28:41Z","timestamp":1678876121000},"page":"e011423","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["The quality of antiretroviral medicines: an uncertain problem"],"prefix":"10.1136","volume":"8","author":[{"given":"Ngan Thi","family":"Do","sequence":"first","affiliation":[{"name":"Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Medicine Quality Research Group, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic"},{"name":"Nuffield Department of Medicine, Infectious Diseases Data Observatory (IDDO)\/WorldWide Antimalarial Resistance Network (WWARN),Medicine Quality Research Group, Oxford University Centre for Tropical Medicine and Global Health, Oxford, UK"},{"name":"Nuffield Department of Medicine, Medicine Quality Research Group, Oxford University Centre for Tropical Medicine and Global Health, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phonepasith","family":"Boupha","sequence":"additional","affiliation":[{"name":"Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Medicine Quality Research Group, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic"},{"name":"Nuffield Department of Medicine, Infectious Diseases Data Observatory (IDDO)\/WorldWide Antimalarial Resistance Network (WWARN),Medicine Quality Research Group, Oxford University Centre for Tropical Medicine and Global Health, Oxford, UK"},{"name":"Nuffield Department of Medicine, Medicine Quality Research Group, Oxford University Centre for Tropical Medicine and Global Health, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0734-2022","authenticated-orcid":false,"given":"Paul N","family":"Newton","sequence":"additional","affiliation":[{"name":"Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Medicine Quality Research Group, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic"},{"name":"Nuffield Department of Medicine, Infectious Diseases Data Observatory (IDDO)\/WorldWide Antimalarial Resistance Network (WWARN),Medicine Quality Research Group, Oxford University Centre for Tropical Medicine and Global Health, Oxford, UK"},{"name":"Nuffield Department of Medicine, Medicine Quality Research Group, Oxford University Centre for Tropical Medicine and Global Health, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5554-2603","authenticated-orcid":false,"given":"C\u00e9line","family":"Caillet","sequence":"additional","affiliation":[{"name":"Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Medicine Quality Research Group, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic"},{"name":"Nuffield Department of Medicine, Infectious Diseases Data Observatory (IDDO)\/WorldWide Antimalarial Resistance Network (WWARN),Medicine Quality Research Group, Oxford University Centre for Tropical Medicine and Global Health, Oxford, UK"},{"name":"Nuffield Department of Medicine, Medicine Quality Research Group, Oxford University Centre for Tropical Medicine and Global Health, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"2025073014555947000_8.3.e011423.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.8431"},{"key":"2025073014555947000_8.3.e011423.2","unstructured":"World Health Organization . HIV. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids [Accessed 6 Sep 2022]."},{"key":"2025073014555947000_8.3.e011423.3","unstructured":"UNICEF . HIV statistics - global and regional trends - UNICEF DATA 2022. Available: https:\/\/data.unicef.org\/topic\/hivaids\/global-regional-trends\/ [Accessed 15 Aug 2022]."},{"key":"2025073014555947000_8.3.e011423.4","unstructured":"UNAIDS . Global HIV & AIDS statistics \u2014 2020 fact sheet. Available: https:\/\/www.unaids.org\/en\/resources\/fact-sheet [Accessed 7 Jul 2020]."},{"key":"2025073014555947000_8.3.e011423.5","unstructured":"World Health Organization . HIV\/AIDS. 2021. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids [Accessed 7 Jul 2021]."},{"key":"2025073014555947000_8.3.e011423.6","unstructured":"World Health Organization . Fact sheet: HIV drug resistance. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-drug-resistance [Accessed 15 Sep 2022]."},{"key":"2025073014555947000_8.3.e011423.7","unstructured":"World Health Organization . HIV drug resistance report 2021. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240038608 [Accessed 15 Sep 2022]."},{"key":"2025073014555947000_8.3.e011423.8","unstructured":"HIV Drugs Market . Global industry trends, share, size, growth, opportunity and forecast 2019-2024. Available: https:\/\/www.researchandmarkets.com\/reports\/4763052\/hiv-drugs-market-global-industry-trends-share#rela4-4987308 [Accessed 7 Jul 2020]."},{"key":"2025073014555947000_8.3.e011423.9","unstructured":"World Health Organization . WHO global surveillance and monitoring system for substandard and falsified medical products. 2017."},{"key":"2025073014555947000_8.3.e011423.10","doi-asserted-by":"crossref","first-page":"e1609","DOI":"10.1016\/S2214-109X(19)30426-7","article-title":"Global access to quality-assured medical products: the oxford statement and call to action","volume":"7","author":"Newton","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2025073014555947000_8.3.e011423.11","unstructured":"World Health Organization . A study on the public health and socioeconomic impact of substandard and falsified medical products. WHO 2018:4\u20138."},{"key":"2025073014555947000_8.3.e011423.12","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-13-139","article-title":"Mind the gaps -- the epidemiology of poor-quality anti-malarials in the malarious world -- analysis of the worldwide antimalarial resistance network database","volume":"13","author":"Tabernero","year":"2014","journal-title":"Malar J"},{"key":"2025073014555947000_8.3.e011423.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-008587","article-title":"Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?","volume":"7","author":"Zabala","year":"2022","journal-title":"BMJ Glob Health"},{"key":"2025073014555947000_8.3.e011423.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001636","article-title":"Quality of medical products for diabetes management: a systematic review","volume":"4","author":"Saraswati","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2025073014555947000_8.3.e011423.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-006523","article-title":"The quality of medical products for cardiovascular diseases: a gap in global cardiac care","volume":"6","author":"Do","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2025073014555947000_8.3.e011423.16","doi-asserted-by":"publisher","DOI":"10.5731\/pdajpst.2017.007567"},{"key":"2025073014555947000_8.3.e011423.17","doi-asserted-by":"crossref","first-page":"23992026211052270","DOI":"10.1177\/23992026211052272","article-title":"Medicine quality in high-income countries: the obstacles to comparative prevalence studies","volume":"5","author":"Naughton","year":"2021","journal-title":"Med Access Point Care"},{"key":"2025073014555947000_8.3.e011423.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006088","article-title":"Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013)","volume":"4","author":"Almuzaini","year":"2014","journal-title":"BMJ Open"},{"key":"2025073014555947000_8.3.e011423.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002924","article-title":"Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001-2011)","volume":"3","author":"Almuzaini","year":"2013","journal-title":"BMJ Open"},{"key":"2025073014555947000_8.3.e011423.20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s43094-020-00112-3","article-title":"Medicine recalls in Saudi Arabia: a retrospective review of drug alerts (January 2010\u2013january 2019)","volume":"6","author":"AlQuadeib","year":"2020","journal-title":"Futur J Pharm Sci"},{"key":"2025073014555947000_8.3.e011423.21","doi-asserted-by":"publisher","DOI":"10.1086\/383575"},{"key":"2025073014555947000_8.3.e011423.22","unstructured":"World Health Organization . Medicines regulatory authorities: current status and the way forward. 2006."},{"key":"2025073014555947000_8.3.e011423.23","unstructured":"CounterfeitDrugs Check combivir, serostim; Epogen"},{"key":"2025073014555947000_8.3.e011423.24","unstructured":"Ravinetto R . [E-drug] counterfeit arvs in DRC. 2004. Available: http:\/\/lists.healthnet.org\/archive\/html\/e-drug\/2004-02\/msg00028.html [Accessed 8 Jul 2020]."},{"key":"2025073014555947000_8.3.e011423.25","unstructured":"World Health Organization . Member state mechanism on substandard\/spurious\/falsely-labelled\/falsified\/ counterfeit medical products. 2017."},{"key":"2025073014555947000_8.3.e011423.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-008564","article-title":"The quality of veterinary medicines and their implications for one health","volume":"7","author":"Vidhamaly","year":"2022","journal-title":"BMJ Glob Health"},{"key":"2025073014555947000_8.3.e011423.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000052","article-title":"Guidelines for field surveys of the quality of medicines: a proposal","volume":"6","author":"Newton","year":"2009","journal-title":"PLoS Med"},{"key":"2025073014555947000_8.3.e011423.28","unstructured":"India Kanoon . Calcutta high court (appellete side) - unknown vs the state of west bengal on 2014; 2014 Nov 14."},{"key":"2025073014555947000_8.3.e011423.29","unstructured":"BBC News . Kenya recalls \u2018faulty\u2019 south korean HIV kits. 2011. n.d. Available: https:\/\/www.bbc.com\/news\/world-africa-16355462?print=true"},{"key":"2025073014555947000_8.3.e011423.30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-002393","article-title":"A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality","volume":"5","author":"McManus","year":"2020","journal-title":"BMJ Glob Health"},{"key":"2025073014555947000_8.3.e011423.31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1685","article-title":"Prevalence of substandard and falsified essential medicines: still an incomplete picture","volume":"1","author":"Mackey","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2025073014555947000_8.3.e011423.32","unstructured":"Mziray S , Maganda BA , Mwamwitwa K . Quality of selected anti-retroviral medicines: tanzania mainland market as a case study. Springer, Available: link.springer.com\/article\/10.1186\/s40360-021-00514-w"},{"key":"2025073014555947000_8.3.e011423.33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000725","article-title":"Field detection devices for screening the quality of medicines: a systematic review","volume":"3","author":"Vickers","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2025073014555947000_8.3.e011423.34","doi-asserted-by":"publisher","DOI":"10.1057\/jphp.2012.53"},{"key":"2025073014555947000_8.3.e011423.35","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8603-4-5","article-title":"Dangerous medicines: unproven AIDS cures and counterfeit antiretroviral drugs","volume":"4","author":"Amon","year":"2008","journal-title":"Global Health"},{"key":"2025073014555947000_8.3.e011423.36","unstructured":"UNAIDS . Fast-track ending the AIDS epidemic by 2030. Available: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC2686_WAD2014report_en.pdf [Accessed 7 Nov 2022]."},{"key":"2025073014555947000_8.3.e011423.37","unstructured":"World Health Organization . Global HIV programme - treatment & care. Available: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/treatment [Accessed 7 Nov 2022]."},{"key":"2025073014555947000_8.3.e011423.38","unstructured":"World Health Organization . Global HIV programme - pre-exposure prophylaxis. Available: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/prevention\/pre-exposure-prophylaxis [Accessed 7 Nov 2022]."},{"key":"2025073014555947000_8.3.e011423.39","unstructured":"World Health Organization . Global state of prep. Available: https:\/\/www.who.int\/groups\/global-prep-network\/global-state-of-prep [Accessed 7 Nov 2022]."},{"key":"2025073014555947000_8.3.e011423.40","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12226"},{"key":"2025073014555947000_8.3.e011423.41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/0956462419841144","article-title":"Quantification of tenofovir disoproxil fumarate and emtricitabine in generic pre-exposure prophylaxis tablets obtained from the Internet","volume":"30","author":"Wang","year":"2019","journal-title":"Int J STD AIDS"},{"key":"2025073014555947000_8.3.e011423.42","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1021\/acs.jchemed.0c00904","article-title":"Involving students in the distributed pharmaceutical analysis laboratory: a citizen-science project to evaluate global medicine quality","volume":"97","author":"Bliese","year":"2020","journal-title":"J Chem Educ"},{"key":"2025073014555947000_8.3.e011423.43","unstructured":"UNAIDS . Global AIDS strategy 2021-2026 \u2014 end inequalities. end AIDS. Available: www.unaids.org\/en\/resources\/documents\/2021\/2021-2026-global-AIDS-strategy [Accessed 8 Nov 2022]."},{"key":"2025073014555947000_8.3.e011423.44","unstructured":"The New Humanitarian . Vietnam\u2019s counterfeit condom crisis. Available: https:\/\/www.thenewhumanitarian.org\/analysis\/2014\/06\/09\/vietnam-s-counterfeit-condom-crisis [Accessed 8 Nov 2022]."},{"key":"2025073014555947000_8.3.e011423.45","unstructured":"Daily Mail Online . Fake condoms warning. Available: https:\/\/www.dailymail.co.uk\/health\/article-341766\/Fake-condoms-warning.html [Accessed 8 Nov 2022]."},{"key":"2025073014555947000_8.3.e011423.46","unstructured":"SecuringIndustry.com . Too short\u2019 condoms lead to counterfeit bust in spain. Available: https:\/\/www.securingindustry.com\/cosmetics-and-personal-care\/-too-short-condoms-lead-to-counterfeit-bust-in-spain\/s106\/a11930\/#.Y2povHbP1hE [Accessed 8 Nov 2022]."},{"key":"2025073014555947000_8.3.e011423.47","unstructured":"Counterfeit condom gang in china broken up. Available: https:\/\/www.businessinsider.com\/counterfeit-condom-gang-in-china-broken-up-2018-11?r=US&IR=T [Accessed 8 Nov 2022]."},{"key":"2025073014555947000_8.3.e011423.48","unstructured":"World Health Organization . WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls 2020. Available: https:\/\/www.who.int\/news\/item\/06-07-2020-who-access-to-hiv-medicines-severely-impacted-by-covid-19-as-aids-response-stalls [Accessed 8 Nov 2022]."}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2022-011423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:56:14Z","timestamp":1753912574000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2022-011423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,15]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/bmjgh-2022-011423"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2022-011423","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}